Grube, Matthias

Autoreactive, cytotoxic T lymphocytes specific for peptides derived from normal B-cell differentiation antigens in healthy individuals and patients with B-cell malignancies. [electronic resource] - Clinical cancer research : an official journal of the American Association for Cancer Research Feb 2004 - 1047-56 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.

1078-0432

10.1158/1078-0432.ccr-03-0075 doi


Adult
Aged
Aged, 80 and over
Antigens--chemistry
Antigens, CD19--biosynthesis
Antigens, CD20--biosynthesis
Antigens, Differentiation, B-Lymphocyte--immunology
B-Lymphocytes--immunology
CD40 Antigens--metabolism
CD8-Positive T-Lymphocytes--metabolism
Cell Line, Tumor
DNA, Complementary--metabolism
Female
Flow Cytometry
HLA-A Antigens--metabolism
HLA-A2 Antigen
Humans
Interferon-gamma--metabolism
Lymphoma, B-Cell--immunology
Male
Middle Aged
Peptides--chemistry
Polymerase Chain Reaction
Protein Binding
RNA--chemistry
RNA, Messenger--metabolism
Reverse Transcriptase Polymerase Chain Reaction
T-Lymphocytes, Cytotoxic--metabolism